deucravacitinib

English

Noun

deucravacitinib (uncountable)

1. (pharmacology) A medication belonging to the class of Janus kinase inhibitors, used for the treatment of moderate-to-severe plaque psoriasis.
   • 2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172:

     Deucravacitinib (BMS-986165) has shown efficacy in a psoriasis trial (65) and significantly greater American College of Rheumatology 20% improvement rates compared to placebo in patients with PsA.